University of Pittsburgh
The new reports link variants in CYP2C19 to the safety and efficacy of two drugs, a commonly prescribed antiplatelet drug and an antidepressant.
OmniSeq, UPMC Partner on Immunotherapy Trial Matching for Head and Neck Cancer
The Phase II trial will use OmniSeq's RNA-seq assay to determine whether patients should be treated with one of two agents combined with BMS' nivolumab.
Genetic Loci Linked to Risk of Rare Takayasu Arteritis Hint at Related Traits
In a genome-wide association study of Takayasu arteritis, researchers uncovered disease-linked loci both within and beyond the HLA region.
Adaptive is rebranding its immunoSeq Dx assay as T-Detect and plans to submit for an EUA for a COVID-19 T-Cell response test by the end of the year.
The program aims to consent up to 150,000 patients to a larger biobank program and return selective preemptive PGx results through their medical center physicians.
Oct 10, 2018
Medicare to Cover UPMC’s Thyroid Nodule Test
Apr 2, 2018
New TCGA Papers Shed Light on Cancer Development
Jan 10, 2018
Aetna to Cover ThyroSeq Thyroid Nodule Test
Sep 26, 2017